MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 112 filers reported holding MIRATI THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.50 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,402,552 | +30.1% | 55,155 | +7.9% | 0.00% | +33.3% |
Q2 2023 | $1,846,207 | -4.7% | 51,099 | -2.0% | 0.00% | 0.0% |
Q1 2023 | $1,937,710 | -17.4% | 52,117 | +0.7% | 0.00% | -25.0% |
Q4 2022 | $2,345,653 | -33.6% | 51,769 | +2.4% | 0.00% | -33.3% |
Q3 2022 | $3,530,000 | +1.8% | 50,541 | -2.1% | 0.01% | +20.0% |
Q2 2022 | $3,467,000 | -17.6% | 51,645 | +1.0% | 0.01% | -16.7% |
Q1 2022 | $4,206,000 | -46.4% | 51,155 | -4.4% | 0.01% | -33.3% |
Q4 2021 | $7,849,000 | -30.2% | 53,504 | -15.9% | 0.01% | -35.7% |
Q3 2021 | $11,253,000 | -3.7% | 63,606 | -12.1% | 0.01% | -6.7% |
Q2 2021 | $11,688,000 | -0.8% | 72,360 | +5.2% | 0.02% | -6.2% |
Q1 2021 | $11,788,000 | -22.2% | 68,815 | -0.3% | 0.02% | -23.8% |
Q4 2020 | $15,158,000 | +49.5% | 69,012 | +13.0% | 0.02% | +31.2% |
Q3 2020 | $10,138,000 | +59.9% | 61,052 | +10.0% | 0.02% | +45.5% |
Q2 2020 | $6,339,000 | +82.4% | 55,524 | +22.8% | 0.01% | +57.1% |
Q1 2020 | $3,475,000 | -35.2% | 45,200 | +8.6% | 0.01% | -22.2% |
Q4 2019 | $5,361,000 | +62.1% | 41,602 | -2.0% | 0.01% | +50.0% |
Q3 2019 | $3,307,000 | -16.5% | 42,443 | +10.3% | 0.01% | -25.0% |
Q2 2019 | $3,962,000 | +64.7% | 38,469 | +17.3% | 0.01% | +60.0% |
Q1 2019 | $2,405,000 | +79.5% | 32,807 | +3.8% | 0.01% | +66.7% |
Q4 2018 | $1,340,000 | -7.8% | 31,595 | +2.4% | 0.00% | 0.0% |
Q3 2018 | $1,454,000 | +6.4% | 30,861 | +11.3% | 0.00% | 0.0% |
Q2 2018 | $1,366,000 | +743.2% | 27,718 | -10.9% | 0.00% | – |
Q1 2017 | $162,000 | +30.6% | 31,094 | +19.2% | 0.00% | – |
Q4 2016 | $124,000 | -29.1% | 26,094 | -1.5% | 0.00% | – |
Q3 2016 | $175,000 | +20.7% | 26,494 | -0.4% | 0.00% | – |
Q2 2016 | $145,000 | -72.1% | 26,594 | +9.5% | 0.00% | -100.0% |
Q1 2016 | $520,000 | -22.7% | 24,294 | +14.1% | 0.00% | -50.0% |
Q4 2015 | $673,000 | -6.9% | 21,291 | +1.4% | 0.00% | 0.0% |
Q3 2015 | $723,000 | +26.4% | 20,991 | +15.4% | 0.00% | +100.0% |
Q2 2015 | $572,000 | +24.9% | 18,191 | +16.4% | 0.00% | 0.0% |
Q1 2015 | $458,000 | +86.9% | 15,632 | +18.1% | 0.00% | 0.0% |
Q4 2014 | $245,000 | +6.1% | 13,232 | +0.4% | 0.00% | 0.0% |
Q3 2014 | $231,000 | -11.8% | 13,175 | +0.6% | 0.00% | 0.0% |
Q2 2014 | $262,000 | – | 13,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 2,881,702 | $14,985,000 | 6.99% |
Avoro Capital Advisors LLC | 2,383,201 | $12,393,000 | 1.58% |
Broadfin Capital, LLC | 2,090,801 | $10,872,000 | 1.32% |
Boxer Capital, LLC | 1,037,994 | $5,398,000 | 1.18% |
Ghost Tree Capital, LLC | 172,184 | $895,000 | 0.17% |
Baker Brothers Advisors | 2,269,198 | $11,800,000 | 0.10% |
Hillhouse Capital Management | 725,000 | $3,770,000 | 0.07% |
SABBY MANAGEMENT, LLC | 249,735 | $1,299,000 | 0.07% |
Rhenman & Partners Asset Management AB | 50,000 | $260,000 | 0.04% |
Trexquant Investment LP | 42,879 | $223,000 | 0.03% |